Martin Shkreli was once dubbed the most hated C-suite executive in America for massively hiking the price of a life-saving drug. Ever since his brief stint in prison, however, Shkreli has built a sizable following on X, courtesy of his surprisingly insightful takes on pharma-focused topics. In keeping with his proclivity to comment on all things pharma-related, Martin Shkreli has just landed a few hard-hitting punches against the new head of FDA’s Center for Biologics Evaluation and Research (CBER), Vinay Prasad. The only “emergency” America still faces with covid-19 is that regulators like Peter Marks are either incompetent or corrupt […]
Read full article at https://wccftech.com/pharma-bro-martin-shkreli-says-the-new-head-of-fdas-cber-vinay-prasad-is-nuts-and-that-pharma-firms-are-gonna-go-out-of-business/
